Incoming Eli Lilly and Co. CEO John Lechleiter can add another feather to his nice-guy hat.
Mike Huckman, who follows the pharmaceutical industry for CNBC, wrote in an online posting this week that he was impressed when he interviewed Lechleiter during an industry gathering Monday.
Lechleiter takes over for retiring Lilly CEO Sidney Taurel on April 1. Taurel will remain chairman of the Indianapolis drugmaker through 2008.
Unlike other CEOs, Lechleiter seemed comfortable operating without an executive assistant or PR person – let alone an entourage.
Lechleiter jokingly blamed his solo status on cost-cutting.
“Lechleiter managed on his own just fine,” Huckman said. “You know what they say about first impressions. Mr. Lechleiter made a big one in my book.”
To read the post, go to http://www.cnbc.com/id/22593149.